Case Study Life Sciences Quality + Compliance Expanding LIMS Functionality with LabVantage: Advanced Analytics for a Gene Therapy Company Clarkston Consulting recently partnered with a gene therapy client on their project of expanding LIMS functionality with LabVantage. Read a ...
Case Study Life Sciences Quality + Compliance Supporting a LabVantage Implementation for a Gene Therapy Company Clarkston Consulting recently completed a Labvantage implementation for a gene therapy company. Read a synopsis of the project below or ...
Case Study Life Sciences Cell and Gene Therapy Creating a CMC Playbook for a Cell and Gene Therapy Company Clarkston Consulting recently partnered with a cell and gene therapy client on a CMC playbook. Read a synopsis of the ...
Multimedia Consulting Services Biotech Commercial Supply Chain Readiness for Biopharma Organizations For emerging biotech and biopharma organizations, ensuring commercial supply chain readiness is critical to achieving success, and there are key ...
Case Study Life Sciences Data + Analytics Interfacing Balance/pH Meter Instruments with a LIMS Platform In this LIMS Instrument Interfacing case study, Clarkston recently partnered with an international pharmaceutical manufacturer whose facility manufactures biologics, monoclonal ...
Blog Post Life Sciences Supply Chain Managing Custom Raw Materials for mRNA Production Below, we dive into managing raw materials for mRNA production – the future of medicine. Read below for an overview ...
Blog Post Life Sciences Cell and Gene Therapy Gene and Cell Therapy Product Documents to Drive Decision-Making A new job at a start-up in the Cell and Gene Therapy (CGT) area is exciting, especially when funding is ...
Case Study Life Sciences Data + Analytics Cell Therapy Data Management This client, a global pharmaceutical company that makes and sells a number of branded prescription drugs, was looking for a ...
Blog Post Life Sciences Cell and Gene Therapy Simplify The Supply Chain for Your Cell Therapy Products Many new cell therapy products are currently in development that are classified as personalized medicine. One subset of that group ...
